1-20 of 55
Authors: Laure Gossec
Journal Article
E090 Guselkumab and IL-17 inhibitors improve patient-perceived impact of psoriatic arthritis similarly: 6-month interim results of the PsABIOnd observational cohort study
Rheumatology, Volume 64, Issue Supplement_3, April 2025, keaf142.325, https://doi.org/10.1093/rheumatology/keaf142.325
Published: 28 April 2025
Journal Article
P174 Bimekizumab-treated patients with active psoriatic arthritis showed sustained improvements in pain and fatigue: up to 2-year results from two Phase 3 studies
Rheumatology, Volume 64, Issue Supplement_3, April 2025, keaf142.211, https://doi.org/10.1093/rheumatology/keaf142.211
Published: 28 April 2025
Journal Article
Variability of Psoriatic Arthritis Impact of Disease questionnaire (PsAID12) thresholds in psoriatic arthritis: data from the ReFlaP study
Rheumatology, Volume 64, Issue 5, May 2025, Pages 3090–3094, https://doi.org/10.1093/rheumatology/keaf002
Published: 03 January 2025
Journal Article
Ultrasonography for the assessment of enthesitis in psoriatic arthritis: systematic review with meta-analysis Get access
Rheumatology, Volume 64, Issue 5, May 2025, Pages 2377–2384, https://doi.org/10.1093/rheumatology/keae705
Published: 20 December 2024
Journal Article
Multi-domain effectiveness of guselkumab evaluated via composite indices through 1 year in patients with PsA and inadequate response to TNFi: post hoc analysis of COSMOS
Rheumatology, Volume 64, Issue 5, May 2025, Pages 2565–2574, https://doi.org/10.1093/rheumatology/keae586
Published: 22 October 2024
Journal Article
Subclinical psoriatic arthritis and disease interception—where are we in 2024?
Rheumatology, Volume 64, Issue 1, January 2025, Pages 56–64, https://doi.org/10.1093/rheumatology/keae399
Published: 16 August 2024
Journal Article
Effect of bimekizumab on patient-reported disease impact in patients with psoriatic arthritis: 1-year results from two phase 3 studies
Rheumatology, Volume 63, Issue 9, September 2024, Pages 2399–2410, https://doi.org/10.1093/rheumatology/keae277
Published: 16 May 2024
Journal Article
OA23 Time to address the challenge of difficult-to-treat psoriatic arthritis: results from an international survey
Rheumatology, Volume 63, Issue Supplement_1, April 2024, keae163.023, https://doi.org/10.1093/rheumatology/keae163.023
Published: 24 April 2024
Journal Article
How do patient-reported outcome measures affect treatment intensification and patient satisfaction in the management of psoriatic arthritis? A cross sectional study of 503 patients
Rheumatology, Volume 64, Issue 1, January 2025, Pages 242–251, https://doi.org/10.1093/rheumatology/kead679
Published: 08 January 2024
Journal Article
An international multicentre analysis of current prescribing practices and shared decision-making in psoriatic arthritis
Rheumatology, Volume 63, Issue 12, December 2024, Pages 3449–3456, https://doi.org/10.1093/rheumatology/kead621
Published: 27 November 2023
Journal Article
P179 Shared decision-making in psoriatic arthritis consultations
Rheumatology, Volume 62, Issue Supplement_2, April 2023, kead104.220, https://doi.org/10.1093/rheumatology/kead104.220
Published: 24 April 2023
Journal Article
P174 Psoriatic arthritis patients in the UK have a lower quality of life than patients in mainland Europe - an analysis from the ASSIST study
Rheumatology, Volume 62, Issue Supplement_2, April 2023, kead104.215, https://doi.org/10.1093/rheumatology/kead104.215
Published: 24 April 2023
Journal Article
P178 Current prescribing practices in psoriatic arthritis - comparison between the UK and Europe
Rheumatology, Volume 62, Issue Supplement_2, April 2023, kead104.219, https://doi.org/10.1093/rheumatology/kead104.219
Published: 24 April 2023
Journal Article
Gender-specific differences in patients with psoriatic arthritis receiving ustekinumab or tumour necrosis factor inhibitor: real-world data
Rheumatology, Volume 62, Issue 10, October 2023, Pages 3382–3390, https://doi.org/10.1093/rheumatology/kead089
Published: 22 February 2023
Journal Article
Evaluation of the agreement between the ACR 1990 fibromyalgia tender points and an enthesitis score in patients with axial spondyloarthritis
Rheumatology, Volume 62, Issue 8, August 2023, Pages 2757–2764, https://doi.org/10.1093/rheumatology/keac683
Published: 27 December 2022
Journal Article
Obstetric outcomes in women with rheumatic disease and COVID-19 in the context of vaccination status
Rheumatology, Volume 62, Issue 4, April 2023, Pages 1621–1626, https://doi.org/10.1093/rheumatology/keac534
Published: 19 September 2022
Journal Article
Effect of bimekizumab on symptoms and impact of disease in patients with psoriatic arthritis over 3 years: results from BE ACTIVE
Rheumatology, Volume 62, Issue 2, February 2023, Pages 617–628, https://doi.org/10.1093/rheumatology/keac353
Published: 05 July 2022
Journal Article
Guselkumab provides sustained domain-specific and comprehensive efficacy using composite indices in patients with active psoriatic arthritis
Rheumatology, Volume 62, Issue 2, February 2023, Pages 606–616, https://doi.org/10.1093/rheumatology/keac375
Published: 29 June 2022
Journal Article
Patient Experienced Symptom State in rheumatoid arthritis: sensitivity to change in disease activity and impact
Rheumatology, Volume 62, Issue 1, January 2023, Pages 98–107, https://doi.org/10.1093/rheumatology/keac257
Published: 28 April 2022
Journal Article
OA01 Safety of vaccination against SARS-CoV-2 in people with rheumatic and musculoskeletal diseases: results from the EULAR Coronavirus Vaccine (COVAX) physician-reported registry
Rheumatology, Volume 61, Issue Supplement_1, May 2022, keac132, https://doi.org/10.1093/rheumatology/keac132
Published: 23 April 2022
